Dietrich John Pauls - President & CEO, Director at DiaMedica Therapeutics Inc.

Insider Transactions and Holdings

Entity type: Individual
Role: President & CEO, Director
Issuer symbol: DMAC on Nasdaq
Source filings: Open source filing history

There are no Buy or Sell transactions made by Dietrich John Pauls since 31 May 2025

Holdings reported by Dietrich John Pauls for DiaMedica Therapeutics Inc.

Form 4 holding President & CEO, Director

DiaMedica Therapeutics Inc.

Security class: Voting Common Shares, no par value per share
Shares / value: 68,591
Estimated value: $253,100
Report date: 01 Jun 2025
Price: $3.69
Ownership: Direct

Form 4 holding President & CEO, Director

DiaMedica Therapeutics Inc.

Security class: Voting Common Shares, no par value per share
Shares / value: 68,591
Estimated value: $192,055
Report date: 01 Jun 2024
Price: $2.80
Ownership: Direct

Form 4 holding President & CEO, Director

DiaMedica Therapeutics Inc.

Security class: Stock Option (right to buy)
Shares / value: 600,000
Estimated value
Report date: 01 Jun 2025
Price
Ownership: Direct
Underlying class: Common Shares
Underlying amount

Transactions reported by Dietrich John Pauls for DiaMedica Therapeutics Inc.

Sym	Class	Transaction	%	Reported value	Reported price	Shares	Shares after	Date	Ownership

^* indicates a reported price that failed the local validity check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .